CDC - STD Surveillance, 2011 - Figure 53

CDC - STD Surveillance, 2011 - Figure 53

2011 Sexually Transmitted Diseases Surveillance

Figure 53. Genital Warts—Initial Visits to Physicians’ Offices, United States, 1966–2011

NOTE: The relative standard errors for genital warts estimates of more than 100,000 range from 18% to 30%. See Other Surveillance Data Sources in the Appendix and Table 44.
SOURCE: IMS Health, Integrated Promotional Services™. IMS Health Report, 1966–2011.
Next Figure

Table of Contents

Introductory Section

• Introductory Section
• Foreword
• Preface
• Guide to Acronyms
• Figures in the National Profile
• Figures in the Special Focus Profiles
• Census Regions of the United States
• National Overview of Sexually Transmitted Diseases (STDs), 2011

National Profile

• National Profile
• Chlamydia
• Gonorrhea
• Syphilis
• Other Sexually Transmitted Diseases

Special Focus Profiles

• Special Focus Profiles
• STDs in Women and Infants
• STDs in Adolescents and Young Adults
• STDs in Racial and Ethnic Minorities
• STDs in Men Who Have Sex with Men
• STDs in Persons Entering Corrections Facilities

Tables

• National Summary
• Chlamydia
• Gonorrhea
• Syphilis
• Chancroid
• Selected STDs

Appendix

• Appendix
• Interpreting STD Surveillance Data
• Appendix Tables A1 - A4
• STD Surveillance Case Definitions
• Contributors

Data & Statistics

Most Recent Data

• Sexually Transmitted Disease Surveillance, 2011 - Annual report of statistics and trends for sexually transmitted diseases in the United States through 2011
  • Slides - Presentation-ready slides of graphs and maps from STD Surveillance, 2011
  • Trends in Sexually Transmitted Diseases 2011  - Summary of trends and highlights of data from the annual report
• Most Recent Profiles
  • Gonococcal Isolate Surveillance Project (GISP) Profiles 2011
  • Syphilis Profiles 2011
  • Chlamydia Profiles 2010

To view older reports, visit the Data & Statistics Archive.

More Data

NCHHSTP Atlas – tool creates maps, charts, and tables of HIV and STD surveillance data

Reportable STDs in Young People 15-24 Years of Age, by State

STD Health Equity
Differences in STD rates by location, gender, age and race.

Indian Health Surveillance - STDs

Other Resources

• Dear Colleague Letter on NCHHSTP Atlas  (January 9, 2012)
• Interactive STD Data 1996-2009 Selected STDs by Age, Gender, and Race 1996-2009
• Data Security and Confidentiality Guidelines  - for HIV, Viral Hepatitis, Sexually Transmitted Disease, and Tuberculosis Programs (December 13, 2011)
• Volume and Type of Laboratory Testing Methods for STDs in Public Health Laboratories 2007  (February 18, 2011) 
• Sexually Transmitted Disease Morbidity Data - interactive search of STD data from 1984-2009 by state or region
• Recommendations for Public Health Surveillance of Syphilis in the United States  - (May 20, 2003)
• STD Surveillance Case Definitions from 2011 Surveillance Report
  • Web Version
  • Print Version 
• Statistics and Data Management Branch (SDMB) Contact List

Figures in the National Profile

Previous Page Next Page: Figures - Special Profiles

1. Table of Contents

Chlamydia

Figure 1. Chlamydia—Rates by Sex, United States, 1991–2011
Figure 2. Chlamydia—Rates by Region, United States, 2002–2011
Figure 3. Chlamydia—Rates by State, United States and Outlying Areas, 2011
Figure 4. Chlamydia—Rates by County, United States, 2011
Figure 5. Chlamydia—Rates by Age and Sex, United States, 2011
Figure 6. Chlamydia—Rates by Race/Ethnicity, United States, 2002–2011
Figure 7. Chlamydia—Cases by Reporting Source and Sex, United States, 2002–2011
Figure 8. Chlamydia—Percentage of Reported Cases by Sex and Selected Reporting Sources, United States, 2011
Figure 9. Chlamydia—Proprotion of Sexually Transmitted Disease (STD) Clinic Patients Testing Positive by Age, Sex, and Sexual Behavior, STD Surveillance Network (SSuN), 2011
Figure 10. Chlamydia—Prevalence Among Persons Aged 14-39 Years by Sex and Survey Cycle, National Health and Nutrition Examination Survey, 1999-2008
Figure 11. Chlamydia—Prevalence Among Persons Aged 14-39 Years by Sex, Race/Ethnicity, or Age Group, National Health and Nutrition Examination Survey, 2005-2008
Figure 12. Chlamydia—Median State-specific Positivity Rates Among Women Aged 15-24 Years Tested in Family Planning Clinics, Infertility Prevention Project, United States, 1997-2011
Figure 13. Chlamydia—Positivity Among Women Aged 15-24 Years Tested In Family Planning Clinics, by State, Infertility Prevention Project, United States and Outlying Areas, 2011
Figure 14. Chlamydia—Trends In Positivity Rates Among Women Aged 15-24 Years Tested in Family Planning Clinics, by U.S. Department of Health and Human Services (HHS) Region, Infertility Prevention Project, 2007-2011
Figure 15. Chlamydia—Percentage of Nucleic Acid Amplification Tests Used Among Women Aged 15-24 Years Tested in Family Planning Clinics, by U.S. Department of Health and Human Services (HHS) Region, Infertility Prevention Project, 2007-2011

Gonorrhea

Figure 16. Gonorrhea—Rates, United States, 1941–2011
Figure 17. Gonorrhea—Rates by Sex, United States, 1991–2011
Figure 18. Gonorrhea—Rates by Region, United States, 2002–2011
Figure 19. Gonorrhea—Rates by State, United States and Outlying Areas, 2011
Figure 20. Gonorrhea—Rates by County, United States, 2011
Figure 21. Gonorrhea—Rates by Age and Sex, United States, 2011
Figure 22. Gonorrhea—Rates by Age Among Women Aged 15–44 Years, United States, 2002–2011
Figure 23. Gonorrhea—Rates by Age Among Men Aged 15–44 Years, United States, 2002–2011
Figure 24. Gonorrhea—Rates by Race/Ethnicity, United States, 2002–2011
Figure 25. Gonorrhea—Cases by Reporting Source and Sex, United States, 2002–2011
Figure 26. Gonorrhea—Percentage of Reported Cases by Sex and Selected Reporting Sources, United States, 2011
Figure 27. Proportion of MSM, MSW, and Women Among Interviewed Gonorrhea Cases by Site, STD Surveillance Network (SSuN), 2011
Figure 28. Gonorrhea—Positivity Among Women Aged 15–24 Years Tested in Family Planning Clinics, by State, Infertility Prevention Project, United States and Outlying Areas, 2011
Figure 29. Location of Participating Sentinel Sites and Regional Laboratories, Gonococcal Isolate Surveillance Project (GISP) United States, 2011
Figure 30. Distribution of Minimum Inhibitory Concentrations (MICs) of Ceftriaxone Among Neisseria gonorrhoeae Isolates, Gonococcal Isolate Surveillance Project (GISP), 2007–2011
Figure 31. Distribution of Minimum Inhibitory Concentrations (MICs) of Cefixime Among Neisseria gonorrhoeae Isolates, Gonococcal Isolate Surveillance Project (GISP) 2009–2011
Figure 32. Distribution of Minimum Inhibitory Concentrations (MICs) of Azithromycin Among Neisseria gonorrhoeae Isolates, Gonococcal Isolate Surveillance Project (GISP) 2007–2011
Figure 33. Percentage of Neisseria gonorrhoeae Isolates that are Cirpofloxacin-Resistant by Sex of Sex Partner, Gonococcal Isolate Surveillance Project (GISP) 1995–2011
Figure 34. Penicillin, Tetracycline, and Ciprofloxacin Resistance Among Neisseria gonorrhoeae Isolates, Gonococcal Isolate Surveillance Project (GISP), 2011
Figure 35. Antimicrobial Drugs Used to Treat Gonorrhea Among Participants, Gonococcal Isolate Surveillance Project (GISP)—1988–2011

Syphilis

Figure 36. Syphilis—Reported Cases by Stage of Infection, United States, 1941–2011
Figure 37. Primary and Secondary Syphilis—by Sex and Sexual Behavior, 33 Areas 2007–2011
Figure 38. Primary and Secondary Syphilis —Rates by Sex and Male-to-Female Rate Ratios, United States, 1990-2011
Figure 39. Primary and Secondary Syphilis—Rates by Region, United States, 2002–2011
Figure 40. Primary and Secondary Syphilis—Rates by State, United States and Outlying Areas, 2011
Figure 41. Primary and Secondary Syphilis—Rates by County, United States, 2011
Figure 42. Primary and Secondary Syphilis—Rates by Age and Sex, United States, 2011
Figure 43. Primary and Secondary Syphilis—Rates by Age Among Women Aged 15–44 Years, United States, 2002–2011
Figure 44. Primary and Secondary Syphilis—Rates by Age Among Men Aged 15–44 Years, United States, 2002–2011
Figure 45. Primary and Secondary Syphilis—Rates by Race/Ethnicity, United States, 2002–2011
Figure 46. Primary and Secondary Syphilis—Reported Cases by Stage, Sex, and Sexual Behavior, United States, 2011
Figure 47. Primary and Secondary Syphilis—Reported Cases by Sex, Sexual Behavior, and Race/Ethnicity, United States, 2011
Figure 48. Primary and Secondary Syphilis—Reported Cases by Reporting Source and Sex, United States, 2002–2011
Figure 49. Primary and Secondary Syphilis—Percentage of Reported Cases by Sex, Sexual Behavior, and Selected Reporting Sources, 2011
Figure 50. Congenital Syphilis—Reported Cases Among Infants by Year of Birth and Rates of Primary and Secondary Syphilis Among Women, United States, 2002–2011

Other Sexually Transmitted Diseases

Figure 51. Chancroid—Reported Cases, United States, 1981–2011
Figure 52. Human Papillomavirus—Prevalence of High-risk and Low-risk Types Among Females Aged 14–59 Years, National Health and Nutrition Examination Survey, 2003–2006
Figure 53. Genital Warts—Initial Visits to Physicians’ Offices, United States, 1966–2011
Figure 54. Genital Warts—Prevalence Among Sexually Transmitted Disease (STD) Clinic Patients by Sex, Sex of Partners, and Site, STD Surveillance Network (SSuN), 2011
Figure 55. Genital Herpes—Initial Visits to Physicians’ Offices, United States, 1966–2011
Figure 56. Herpes Simplex Virus Type 2—Seroprevalence in Non-Hispanic Whites and Non-Hispanic Blacks by Age Group, National Health and Nutrition Examination Survey, 1976–1980, 1988–1994, 1999–2004, 2005–2008
Figure 57. Trichomoniasis and Other Vaginal Infections—Women—Initial Visits to Physicians’ Offices, United States, 1966–2011